STOCK TITAN

[8-K] Wintrust Financial Corp Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

AMREP Corporation (AXR) Form 4: President & CEO Christopher V. Vitale acquired 8,000 shares of common stock on 17 Jul 2025 via a $0 cost restricted-stock grant under the 2016 Equity Compensation Plan. The award vests in three tranches: 2,666 shares on 17 Jul 2026, 2,667 shares on 17 Jul 2027 and 2,667 shares on 17 Jul 2028, conditional on continued employment. Following the grant, Vitale’s direct beneficial ownership rises to 117,200 shares. No derivative transactions or dispositions were reported. The filing represents routine executive equity compensation designed to retain and align the CEO with long-term shareholder interests; dilution impact is expected to be immaterial given AMREP’s small share count.

AMREP Corporation (AXR) Modulo 4: Il Presidente e CEO Christopher V. Vitale ha acquisito 8.000 azioni ordinarie il 17 luglio 2025 tramite una concessione di azioni vincolate a costo zero nell'ambito del Piano di Compensazione Azionaria 2016. Il premio sarà maturato in tre tranche: 2.666 azioni il 17 luglio 2026, 2.667 azioni il 17 luglio 2027 e 2.667 azioni il 17 luglio 2028, subordinatamente alla continuazione del rapporto di lavoro. Dopo la concessione, la proprietà diretta di Vitale sale a 117.200 azioni. Non sono state segnalate operazioni o cessioni di derivati. La comunicazione rappresenta una normale compensazione azionaria per dirigenti, finalizzata a trattenere e allineare il CEO con gli interessi azionari a lungo termine; l'impatto diluitivo è previsto irrilevante dato il basso numero di azioni AMREP.

AMREP Corporation (AXR) Formulario 4: El presidente y CEO Christopher V. Vitale adquirió 8,000 acciones ordinarias el 17 de julio de 2025 mediante una concesión de acciones restringidas sin costo bajo el Plan de Compensación de Capital 2016. La adjudicación se consolida en tres partes: 2,666 acciones el 17 de julio de 2026, 2,667 acciones el 17 de julio de 2027 y 2,667 acciones el 17 de julio de 2028, condicionado a la continuidad laboral. Tras la concesión, la propiedad directa de Vitale aumenta a 117,200 acciones. No se reportaron transacciones o disposiciones de derivados. La presentación representa una compensación ejecutiva habitual diseñada para retener y alinear al CEO con los intereses de los accionistas a largo plazo; se espera que el impacto dilutivo sea insignificante dado el bajo número de acciones de AMREP.

AMREP Corporation (AXR) Form 4: 사장 겸 CEO 크리스토퍼 V. 비탈레는 2025년 7월 17일 2016년 주식 보상 계획에 따른 0원 비용 제한 주식 부여를 통해 8,000주 보통주를 취득했습니다. 이 수여는 세 차례에 걸쳐 베스팅되며, 2026년 7월 17일에 2,666주, 2027년 7월 17일에 2,667주, 2028년 7월 17일에 2,667주가 계속 고용 조건 하에 지급됩니다. 수여 후 비탈레의 직접 소유 주식은 117,200주로 증가합니다. 파생상품 거래나 처분은 보고되지 않았습니다. 이 제출은 CEO를 장기 주주 이익과 일치시키고 유지하기 위한 일상적인 임원 주식 보상이며, AMREP의 적은 주식 수로 인해 희석 영향은 미미할 것으로 예상됩니다.

AMREP Corporation (AXR) Formulaire 4 : Le président-directeur général Christopher V. Vitale a acquis 8 000 actions ordinaires le 17 juillet 2025 via une attribution d’actions restreintes sans coût dans le cadre du Plan de Compensation en Actions 2016. Cette attribution est acquise en trois tranches : 2 666 actions le 17 juillet 2026, 2 667 actions le 17 juillet 2027 et 2 667 actions le 17 juillet 2028, sous réserve de la poursuite de l’emploi. Après cette attribution, la propriété directe de Vitale s’élève à 117 200 actions. Aucune transaction ou disposition dérivée n’a été rapportée. Ce dépôt représente une rémunération exécutive habituelle visant à retenir le PDG et à aligner ses intérêts sur ceux des actionnaires à long terme ; l’impact dilutif est attendu comme négligeable compte tenu du faible nombre d’actions AMREP.

AMREP Corporation (AXR) Formular 4: Präsident und CEO Christopher V. Vitale erwarb am 17. Juli 2025 8.000 Stammaktien durch eine kostenfreie Restricted-Stock-Zuteilung im Rahmen des Equity Compensation Plans 2016. Die Zuteilung erfolgt in drei Tranchen: 2.666 Aktien am 17. Juli 2026, 2.667 Aktien am 17. Juli 2027 und 2.667 Aktien am 17. Juli 2028, jeweils unter der Bedingung fortgesetzter Anstellung. Nach der Zuteilung steigt Vitales direkte Beteiligung auf 117.200 Aktien. Es wurden keine derivative Transaktionen oder Veräußerungen gemeldet. Die Meldung stellt eine routinemäßige Vergütung von Führungskräften dar, die darauf abzielt, den CEO zu binden und langfristig mit den Interessen der Aktionäre in Einklang zu bringen; die Verwässerung wird angesichts der geringen Aktienzahl von AMREP als unerheblich eingeschätzt.

Positive
  • Alignment of interests: Grant increases CEO’s equity stake to 117,200 shares, strengthening management-shareholder alignment.
  • Retention mechanism: Three-year vesting schedule encourages leadership stability through 2028.
Negative
  • Minor dilution: Issuance of 8,000 new shares marginally increases share count and adds future compensation expense.

Insights

TL;DR – Routine CEO grant; alignment positive, financial impact negligible.

The 8,000-share restricted-stock grant equals roughly 6.8% of Vitale’s post-grant holdings and vests over three years, incentivising retention and long-term value creation. Because the award was issued at no cost, AMREP will record non-cash compensation expense over the vesting period, but the absolute share count impact is minor relative to AMREP’s c.8.4 million shares outstanding. No open-market buying or selling occurred, so market-signal value is limited. Overall, the filing is neutral for valuation yet modestly positive for governance due to increased management ownership.

AMREP Corporation (AXR) Modulo 4: Il Presidente e CEO Christopher V. Vitale ha acquisito 8.000 azioni ordinarie il 17 luglio 2025 tramite una concessione di azioni vincolate a costo zero nell'ambito del Piano di Compensazione Azionaria 2016. Il premio sarà maturato in tre tranche: 2.666 azioni il 17 luglio 2026, 2.667 azioni il 17 luglio 2027 e 2.667 azioni il 17 luglio 2028, subordinatamente alla continuazione del rapporto di lavoro. Dopo la concessione, la proprietà diretta di Vitale sale a 117.200 azioni. Non sono state segnalate operazioni o cessioni di derivati. La comunicazione rappresenta una normale compensazione azionaria per dirigenti, finalizzata a trattenere e allineare il CEO con gli interessi azionari a lungo termine; l'impatto diluitivo è previsto irrilevante dato il basso numero di azioni AMREP.

AMREP Corporation (AXR) Formulario 4: El presidente y CEO Christopher V. Vitale adquirió 8,000 acciones ordinarias el 17 de julio de 2025 mediante una concesión de acciones restringidas sin costo bajo el Plan de Compensación de Capital 2016. La adjudicación se consolida en tres partes: 2,666 acciones el 17 de julio de 2026, 2,667 acciones el 17 de julio de 2027 y 2,667 acciones el 17 de julio de 2028, condicionado a la continuidad laboral. Tras la concesión, la propiedad directa de Vitale aumenta a 117,200 acciones. No se reportaron transacciones o disposiciones de derivados. La presentación representa una compensación ejecutiva habitual diseñada para retener y alinear al CEO con los intereses de los accionistas a largo plazo; se espera que el impacto dilutivo sea insignificante dado el bajo número de acciones de AMREP.

AMREP Corporation (AXR) Form 4: 사장 겸 CEO 크리스토퍼 V. 비탈레는 2025년 7월 17일 2016년 주식 보상 계획에 따른 0원 비용 제한 주식 부여를 통해 8,000주 보통주를 취득했습니다. 이 수여는 세 차례에 걸쳐 베스팅되며, 2026년 7월 17일에 2,666주, 2027년 7월 17일에 2,667주, 2028년 7월 17일에 2,667주가 계속 고용 조건 하에 지급됩니다. 수여 후 비탈레의 직접 소유 주식은 117,200주로 증가합니다. 파생상품 거래나 처분은 보고되지 않았습니다. 이 제출은 CEO를 장기 주주 이익과 일치시키고 유지하기 위한 일상적인 임원 주식 보상이며, AMREP의 적은 주식 수로 인해 희석 영향은 미미할 것으로 예상됩니다.

AMREP Corporation (AXR) Formulaire 4 : Le président-directeur général Christopher V. Vitale a acquis 8 000 actions ordinaires le 17 juillet 2025 via une attribution d’actions restreintes sans coût dans le cadre du Plan de Compensation en Actions 2016. Cette attribution est acquise en trois tranches : 2 666 actions le 17 juillet 2026, 2 667 actions le 17 juillet 2027 et 2 667 actions le 17 juillet 2028, sous réserve de la poursuite de l’emploi. Après cette attribution, la propriété directe de Vitale s’élève à 117 200 actions. Aucune transaction ou disposition dérivée n’a été rapportée. Ce dépôt représente une rémunération exécutive habituelle visant à retenir le PDG et à aligner ses intérêts sur ceux des actionnaires à long terme ; l’impact dilutif est attendu comme négligeable compte tenu du faible nombre d’actions AMREP.

AMREP Corporation (AXR) Formular 4: Präsident und CEO Christopher V. Vitale erwarb am 17. Juli 2025 8.000 Stammaktien durch eine kostenfreie Restricted-Stock-Zuteilung im Rahmen des Equity Compensation Plans 2016. Die Zuteilung erfolgt in drei Tranchen: 2.666 Aktien am 17. Juli 2026, 2.667 Aktien am 17. Juli 2027 und 2.667 Aktien am 17. Juli 2028, jeweils unter der Bedingung fortgesetzter Anstellung. Nach der Zuteilung steigt Vitales direkte Beteiligung auf 117.200 Aktien. Es wurden keine derivative Transaktionen oder Veräußerungen gemeldet. Die Meldung stellt eine routinemäßige Vergütung von Führungskräften dar, die darauf abzielt, den CEO zu binden und langfristig mit den Interessen der Aktionäre in Einklang zu bringen; die Verwässerung wird angesichts der geringen Aktienzahl von AMREP als unerheblich eingeschätzt.

0001015328false00010153282025-07-212025-07-210001015328us-gaap:CommonStockMember2025-07-212025-07-210001015328us-gaap:SeriesDPreferredStockMember2025-07-212025-07-210001015328wtfc:DepositarySharesSeriesEPreferredStockMember2025-07-212025-07-210001015328wtfc:DepositorySharesSeriesFPreferredStockMember2025-07-212025-07-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
Current Report
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 21, 2025
 
WINTRUST FINANCIAL CORPORATION
(Exact name of registrant as specified in its charter)
 
Illinois001-35077 36-3873352
(State or other jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer
Identification No.)
9700 W. Higgins Road, Suite 800
RosemontIllinois 60018
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code (847939-9000
Not Applicable
(Former name or former address, if changed since last year)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of Each Class Ticker SymbolName of Each Exchange on Which Registered
Common Stock, no par value WTFCThe Nasdaq Global Select Market
Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series D, no par valueWTFCMThe Nasdaq Global Select Market
Depositary Shares, Each Representing a 1/1,000th Interest in a Share of
WTFCPThe Nasdaq Global Select Market
6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series E, no par value
Depositary Shares, Each Representing a 1/1,000th Interest in a Share of
WTFCNThe Nasdaq Global Select Market
7.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series F, no par value

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company     
    
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     



Item 2.02. Results of Operations and Financial Condition
The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
On July 21, 2025, Wintrust Financial Corporation (the “Company”) announced earnings for the second quarter of 2025 and posted on its website the Second Quarter 2025 Earnings Release Presentation. Copies of the press release relating to the Company’s earnings results and the related presentation are attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively. Certain supplemental information relating to non-GAAP financial measures reported in the attached press release and presentation is included on pages 33 through 34 of Exhibit 99.1 and pages 30 through 32 of Exhibit 99.2.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
 
Exhibit
  
99.1
Second Quarter 2025 Earnings Release dated July 21, 2025
99.2
Second Quarter 2025 Earnings Release Presentation dated July 21, 2025
2


Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
WINTRUST FINANCIAL CORPORATION
(Registrant)
By:/s/ David L. Stoehr
 David L. Stoehr
Executive Vice President and
    Chief Financial Officer
Date: July 21, 2025
3


INDEX TO EXHIBITS
 
Exhibit
  
99.1
Second Quarter 2025 Earnings Release dated July 21, 2025
99.2
Second Quarter 2025 Earnings Release Presentation dated July 21, 2025

4

FAQ

How many AXR shares did CEO Christopher Vitale acquire in the Form 4?

8,000 common shares were granted on 17 Jul 2025.

What is the vesting schedule for the restricted stock granted to AXR's CEO?

2,666 shares vest on 17 Jul 2026, 2,667 on 17 Jul 2027, and 2,667 on 17 Jul 2028.

What is Christopher Vitale’s total beneficial ownership after the transaction?

He now directly owns 117,200 AXR shares.

Was there any cash consideration for the shares acquired?

No. The restricted shares were granted at a $0 purchase price.

Did the Form 4 report any stock sales or derivative transactions?

No sales or derivative activity was disclosed—only the restricted-stock grant.

Under which plan were the restricted shares granted to AXR's CEO?

The shares were issued under the AMREP Corporation 2016 Equity Compensation Plan.
Wintrust Fincl

NASDAQ:WTFC

WTFC Rankings

WTFC Latest News

WTFC Latest SEC Filings

WTFC Stock Data

8.89B
65.86M
1.48%
96.58%
2.46%
Banks - Regional
State Commercial Banks
Link
United States
ROSEMONT